Bill > S1181

This bill, concerning epilepsy medications in New Jersey, establishes new rules for pharmacists regarding the substitution of prescribed drugs. Specifically, it prohibits a pharmacist from switching a patient's anti-epileptic drug, which is any medication prescribed for epilepsy or to prevent seizures, with another version without first notifying and getting written consent from both the prescribing doctor and the patient (or their legal representative). The bill defines "epilepsy" as a neurological condition causing recurring seizures, and a "seizure" as a sudden change in behavior or sensation due to abnormal brain electrical activity. "Interchange" is broadly defined to include substituting a generic for a brand-name drug, a different manufacturer's generic for another, a different formulation of the same drug, or even a different anti-epileptic drug altogether. This legislation aims to ensure that any changes to a patient's epilepsy medication are made with the full knowledge and agreement of both the medical professional and the individual receiving treatment.